Filing Details
- Accession Number:
- 0001104659-18-031860
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-09 21:16:12
- Reporting Period:
- 2018-05-02
- Accepted Time:
- 2018-05-09 21:16:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1609550 | Inspire Medical Systems Inc. | INSP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1459212 | Joyce Erony | C/O Inspire Medical Systems, Inc. 9700 63Rd Avenue North, Suite 200 Maple Grove MN 55369 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-05-07 | 1,372,043 | $0.00 | 1,372,043 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2018-05-07 | 125,000 | $16.00 | 1,497,043 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series F Convertible Preferred Stock | Disposition | 2018-05-07 | 9,124,088 | $0.00 | 1,372,043 | $0.00 |
Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2015-05-02 | 17,296 | $0.00 | 17,296 | $16.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
17,296 | 2028-05-02 | No | 4 | A | Direct |
Footnotes
- Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended). These shares had no expiration date.
- These shares are held of record by Amzak Health Investors, LLC ("Amzak Health"). Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health. Ms. Erony disclaims beneficial ownership of the shares held by Amzak Health except to the extent of her proportionate pecuniary interest therein.
- The option vests and becomes exercisable on May 2, 2019, subject to the Reporting Person's continuous service to the Issuer through such date. The option was erroneously included on the Reporting Person's Form 3 filed on May 2, 2018.